Science brief
Lost Skies and Local Defenses
The UK defunds its most historic radio telescope as immunologists map the lungs' secret defense network.
Science
The UK is abandoning its most iconic domestic radio telescope to fund global mega-projects — a shift that could end its status as a top-tier space observation hub.
BackgroundThe 70-year-old Lovell Telescope is a landmark of global astronomy that tracked early space probes and mapped distant quasars. It serves as the heart of the UK's domestic radio telescope network, linking deep-space dishes across the country to act as one giant lens.
- Prominent astrophysicists warned the cuts will inflict irreversible damage on the UK’s research standing, potentially forcing the complete closure of the historic Jodrell Bank observatory.
- The funding body is prioritizing international mega-projects like the Square Kilometre Array, leaving domestic research infrastructure vulnerable to decay as local facilities lose state support.
- Astronomers must now scramble to secure alternative funding from regional authorities, university partnerships, or private donors before the March 2028 deadline to keep the dishes turning.
Science
A massive reservoir of resident immune cells permanently defends human lung tissue — a discovery showing that effective respiratory vaccines must target local organs rather than circulating blood.
BackgroundMost clinical immunology research relies on blood samples because circulating cells are easy to extract and analyze. However, many specialized immune defenses reside permanently inside solid organs, meaning their full role in fighting disease has historically been overlooked.
- Researchers found these lung-resident T cells never enter the bloodstream, operating instead as a permanent local security force that instantly neutralizes viruses like influenza and RSV.
- The physical architecture of the lung acts as a specialized microenvironment, providing the necessary signals to keep these protective cells alive and active for years.
- The findings indicate that future respiratory vaccines must trigger localized tissue immunity within the lungs rather than relying on systemic blood antibodies, which often fail to prevent infection.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.